Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On Friday 29 September hundreds of researchers took to Oxford’s streets, gardens, museums and libraries to take part in the Curiosity Carnival, an event which celebrated and debated the way that research affects all our lives. Part of European Researcher’s Night, it was one of hundreds of events taking place across Europe.

Over 9000 people took part in activities led by researchers from across all Divisions, as well as from partner organisations Oxford Brookes University and MRC Harwell. 

"The Curiosity Carnival is another first for Oxford. We are delighted to have this opportunity to showcase our world leading research, and engage with the community on projects that will shape all our futures." - Professor Louise Richardson, Vice Chancellor of the University of Oxford

Medical Sciences Division researchers were out in force to bring their research to the public. Musical numbers attracted lots of attention, with the Oxford Belles helping psychologist Robin Dunbar explore singing and social cohesion, while the Sleep and Circadian Neuroscience Institute organised a concert with the Orchestra of the Age of Enlightenment on the science of sleep.

Among many other highlights, attendees were invited to ‘Knit-a-Neuron’ with Emma Palmer-Cooper, have a go at doing an endoscopy with Claire Pearson, and attend a dance performance of heart rhythms with researchers from the Radcliffe Department of Medicine. 

Read more (University of Oxford website)

#CuriosityCarnival Tweets

Similar stories

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Coronavirus COVID-19 General Research

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.